What We Do
The Experimental Therapeutics Research Laboratory, under the direction of Robert A. Floyd, Ph.D., focuses on new discoveries in biomedical research and their role in the development of novel therapeutic approaches for treating important human diseases. At this critical interface, which is often underserved in the biomedical research arena, researchers can pose creative new scientific questions and conduct experiments to evaluate if novel therapeutics can arise.
Our Scientists
Robert A. Floyd, Ph.D.Member
Our Publications
2012
Choi CH, Chen K, Du X, Floyd RA, Kopke RD. Effects of delayed and extended antioxidant treatment on acute acoustic trauma. Free Radic Res 45:1162-1172, 2011. [Abstract] EPub
Du X, Chen K, Choi CH, Li W, Cheng W, Stewart C, Hu N, Floyd RA, Kopke RD. Selective degeneration of synapses in the dorsal cochlear nucleus of chinchilla following acoustic trauma and effects of antioxidant treatment. Hear Res 283:1-13, 2012.. [Abstract]
Ewert DL, Lu J, Li W, Du X, Floyd R, Kopke R. Antioxidant treatment reduces blast-induced cochlear damage and hearing loss. Hear Res 2012. [Abstract] EPub
* Indicates publications by more than one department.
Contact Us
Robert A. Floyd, Ph.D., Program Head
Experimental Therapeutics Research Program
Oklahoma Medical Research Foundation
825 Northeast 13th Street
Oklahoma City, OK 73104
Phone: (405) 271-7580
Fax: (405) 271-1795
Email: Robert-Floyd@omrf.org
